… and enterococcal isolates from infections in patients housed in … Pseudomonas aeruginosa
and Acinetobacter baumannii have developed resistance to multiple antimicrobial agents …

… revealed the importance of this finding in the introduction of novel agents that target P. …
antimicrobial agents, we propose a novel strategy for treatment of dangerous MDR infections …

… To develop new efficacious antimicrobial agents, it is necessary to know the pathways …
mechanisms of virulence and antibacterial resistance is crucial to identify new biological targets. …

… to antimicrobial drugs currently used for the treatment of … baumannii; however, Spanish
researchers have identified … Considering the issues presented previously, we will further discuss …

… , Acinetobacter baumannii, Pseudomonas aeruginosa, and … baumannii infections, there is
mounting pressure to find new … While A.baumannii remains a major public health challenge …

… of Pseudomonas aeruginosa isolates to these same antibiotics … entirely new targets for
antibacterial drugs could be identified, … cost of developing a new antibacterial agent is not justified …

… It is intrinsically resistant to many antimicrobial agents and additional acquired … to
ceftolozane-tazobactam has been identified in P. … aeruginosa, in challenging clinical situations …

… Bacterial biofilms still remain a challenge to the healthcare system due to their resilience
against antimicrobial agents and immune system. Moreover, mechanisms involved in biofilm …

… , Pseudomonas aeruginosa and Acinetobacter baumannii. Several treatment options are …
[23, 24], allowing even earlier identification of the mechanisms of resistance and targeted …

… baumannii, with the objective of identifying the most … that effectively escape the effects
of antibacterial drugs [16]. … such as Pseudomonas aeruginosa, Acinetobacter baumannii, …